Skip to main content

Early Detection

Advances research to determine the effectiveness and clinical impact – harms and benefits – of cancer early detection technologies and practices, including imaging and molecular biomarker approaches. Fosters technological development, statistical modeling, and dissemination of scientific findings to promote early cancer detection practices.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Resources

Cancer Data Access System (CDAS)

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	LeeVan, Elyse, M.D., M.P.H. elyse.leevan@nih.gov 240-276-7314	5E110	Program Officer \| Early Detection
	McCarty, Larae larae.mccarty@nih.gov 240-276-5777	5E322	Program Specialist \| Community Oncology and Prevention Trials Early Detection
	Miller, Eric, Ph.D. eric.miller2@nih.gov 240-276-5336	5E212	Program Officer \| Early Detection
	Ong, Mary Jane maryjane.ong@nih.gov 240-858-3296	5E120	Nurse Consultant \| Early Detection
	Pinsky, Paul, Ph.D. paul.pinsky@nih.gov 240-276-7014	5E108	Chief \| Early Detection
	Saxena, Neeraj, Ph.D. neeraj.saxena@nih.gov 240-276-6302	5E218	Program Officer \| Early Detection
	Zhu, Claire, Ph.D. claire.zhu@nih.gov 240-276-7013	5E106	Program Officer \| Early Detection

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Yaddanapudi, Kavitha	University Of Louisville United States	A Stem Cell Based Exosomal Vaccine for the Prevention of Cancer	5R21CA277314-02
Yaghjyan, Lusine	University Of Florida United States	Stromal contributions to breast carcinogenesis	5R01CA277817-03	Christos Patriotis, Ph.D., M.Sc.
Yang, Wan	Columbia University Health Sciences United States	UNCOVER: underlying novel causes of onset of very early cancer research	5R01CA257971-05	Nicholas Hodges, Ph.D.
Yang, Qing	University Of Texas Med Br Galveston United States	The role of acute excitation of sensory neurons in the development of paclitaxel-induced peripheral neuropathy	5R01CA273001-02	Rachel Altshuler, Ph.D.
Yeh, Jennifer M.	Boston Children'S Hospital United States	Can risk-reducing medications improve breast cancer prevention in childhood and adolescent cancer survivors? Comparative modeling to inform care	5R01CA261874-04	Eileen Dimond, R.N., M.S.
Yendamuri, Saikrishna	Roswell Park Cancer Institute Corp United States	Metformin for chemoprevention of lung cancer in obese subjects at high risk	5R01CA255515-05	Malgorzata Wojtowicz, M.D.
Yilmaz, Omer	Massachusetts Institute Of Technology United States	PROSPECT - Stem cell models	3OT2CA297570-01S1	Asad Umar, D.V.M., Ph.D.
You, Ming	Methodist Hospital Research Institute United States	Targeting phenethyl isothiocyanate to mitochondria in lung carcinogenesis	5R01CA280746-02	John Clifford, Ph.D.
Young, Steven L	Duke University United States	Collaborative Center to Develop Improved Diagnostic and Therapeutic Approaches to Endometriosis	5P01HD106485-05	Goli Samimi, Ph.D., M.P.H.
Yu, Dihua	University Of Tx Md Anderson Can Ctr United States	Exploring novel strategies for immunoprevention of estrogen receptor negative breast cancer	5R01CA270010-03	Marjorie Perloff, M.D.
Yu, Anthony Francis	Sloan-Kettering Inst Can Research United States	Intensive Blood Pressure Control During Cardiotoxic Breast Cancer Treatment (PROTECT) Trial	5R37CA273923-03	Eileen Dimond, R.N., M.S.
Yu, Danxia	Vanderbilt University Medical Center United States	Gut microbiota-related mechanisms that impact colorectal cancer risk after bariatric surgery	5R01CA275864-03	Edward Sauter, M.D., Ph.D.
Yuan, Ying	University Of Tx Md Anderson Can Ctr United States	Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions	5U24CA274212-04	Christos Patriotis, Ph.D., M.Sc.
Zarrinpar, Amir	University Of California, San Diego United States	Engineering Native E. coli to Detect, Report, and Treat Colorectal Cancer	5U01CA265719-05	Guillermo Marquez, Ph.D.
Zeng, Melody Yue	Weill Medical Coll Of Cornell Univ United States	Dissecting the interplay between immunoglobulin G and the gut microbiome in cancer progression and metastasis	5R21CA270998-02	Young Kim, Ph.D.